| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | GRAM | 1.11e-03 | 16 | 58 | 2 | SM00568 | |
| Domain | GRAM | 2.10e-03 | 22 | 58 | 2 | PF02893 | |
| Domain | GRAM | 2.10e-03 | 22 | 58 | 2 | IPR004182 | |
| Pubmed | Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. | 3.13e-06 | 2 | 62 | 2 | 17920818 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 1512460 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24676719 | ||
| Pubmed | What's new in the pathogeneses and triggering factors of bullous pemphigoid. | 3.13e-06 | 2 | 62 | 2 | 36412277 | |
| Pubmed | 8.07e-06 | 407 | 62 | 7 | 12693553 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 2045679 | ||
| Pubmed | 1.20e-05 | 285 | 62 | 6 | 34369648 | ||
| Pubmed | Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes. | 1.87e-05 | 4 | 62 | 2 | 14668477 | |
| Pubmed | Ligand-of-Numb protein X is an endocytic scaffold for junctional adhesion molecule 4. | 1.87e-05 | 4 | 62 | 2 | 16832352 | |
| Pubmed | MERIT40 cooperates with BRCA2 to resolve DNA interstrand cross-links. | 1.87e-05 | 4 | 62 | 2 | 26338419 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FAM89A DST SBF1 PPP1R15B ZFYVE26 BTAF1 NUP214 TBC1D9 GGA3 C2CD2L | 2.41e-05 | 1105 | 62 | 10 | 35748872 |
| Pubmed | The nuclear pore complex: from molecular architecture to functional dynamics. | 3.12e-05 | 5 | 62 | 2 | 10395558 | |
| Pubmed | Structure and function of hemidesmosomes: more than simple adhesion complexes. | 3.12e-05 | 5 | 62 | 2 | 10201522 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.96e-05 | 934 | 62 | 9 | 33916271 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 10637308 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 8432531 | ||
| Pubmed | Elongator and codon bias regulate protein levels in mammalian peripheral neurons. | 6.53e-05 | 7 | 62 | 2 | 29497044 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 6.53e-05 | 565 | 62 | 7 | 25468996 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 31306714 | ||
| Pubmed | 1.08e-04 | 263 | 62 | 5 | 34702444 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 12482924 | ||
| Pubmed | 1.61e-04 | 152 | 62 | 4 | 34299191 | ||
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 1.70e-04 | 11 | 62 | 2 | 8707838 | |
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 12802069 | ||
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 10811835 | ||
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 1.70e-04 | 11 | 62 | 2 | 16757171 | |
| Pubmed | Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells. | 2.41e-04 | 13 | 62 | 2 | 28636595 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 9670011 | ||
| Pubmed | 4.18e-04 | 17 | 62 | 2 | 11001876 | ||
| Pubmed | 5.82e-04 | 20 | 62 | 2 | 33397958 | ||
| Pubmed | Genome-wide association studies identify four ER negative-specific breast cancer risk loci. | 6.42e-04 | 21 | 62 | 2 | 23535733 | |
| Pubmed | 7.09e-04 | 225 | 62 | 4 | 12168954 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 8.38e-04 | 861 | 62 | 7 | 36931259 | |
| Pubmed | 9.14e-04 | 25 | 62 | 2 | 10601273 | ||
| Pubmed | 9.27e-04 | 634 | 62 | 6 | 34591612 | ||
| Pubmed | 9.32e-04 | 421 | 62 | 5 | 36976175 | ||
| Pubmed | 9.89e-04 | 26 | 62 | 2 | 12228227 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.13e-03 | 440 | 62 | 5 | 34244565 | |
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 1.32e-03 | 30 | 62 | 2 | 24315095 | |
| Pubmed | A genetic linkage map of the mouse: current applications and future prospects. | 1.32e-03 | 30 | 62 | 2 | 8211130 | |
| Pubmed | 1.32e-03 | 30 | 62 | 2 | 19409883 | ||
| Pubmed | 1.32e-03 | 30 | 62 | 2 | 27016207 | ||
| Pubmed | 1.38e-03 | 1215 | 62 | 8 | 15146197 | ||
| Pubmed | 1.54e-03 | 127 | 62 | 3 | 30442766 | ||
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 1.57e-03 | 128 | 62 | 3 | 25332235 | |
| Pubmed | 1.68e-03 | 131 | 62 | 3 | 28031328 | ||
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 1.69e-03 | 34 | 62 | 2 | 18539113 | |
| Pubmed | 1.70e-03 | 285 | 62 | 4 | 32838362 | ||
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma|TCGA-Uterus / Sample_Type by Project: Shred V9 | 2.21e-06 | 151 | 62 | 5 | 2810bfa01bd3016aeba29735eb4a9284792e8aac | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-06 | 160 | 62 | 5 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 3.21e-06 | 163 | 62 | 5 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-05 | 160 | 62 | 4 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.32e-05 | 160 | 62 | 4 | 04714d0b9bad4c11fa193ed168e2d84a4df39e2e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-05 | 168 | 62 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-05 | 169 | 62 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 177 | 62 | 4 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 179 | 62 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-04 | 179 | 62 | 4 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-04 | 180 | 62 | 4 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-04 | 180 | 62 | 4 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.20e-04 | 182 | 62 | 4 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.25e-04 | 184 | 62 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-04 | 185 | 62 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 1.28e-04 | 185 | 62 | 4 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 185 | 62 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 185 | 62 | 4 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 62 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 187 | 62 | 4 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.42e-04 | 190 | 62 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 191 | 62 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-04 | 192 | 62 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.51e-04 | 193 | 62 | 4 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 193 | 62 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 194 | 62 | 4 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-04 | 194 | 62 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | CF-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.54e-04 | 194 | 62 | 4 | 3feb8a0ba3368673c53e9cbd4980e73d18697718 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 195 | 62 | 4 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 195 | 62 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.57e-04 | 195 | 62 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 195 | 62 | 4 | d6e2a5a15bea16de5f7ff09318c67d46ea923203 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-04 | 196 | 62 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 197 | 62 | 4 | d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-04 | 197 | 62 | 4 | 33f2fe101ae5744eea3915add37e60aa398bb97f | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-04 | 197 | 62 | 4 | 5e9a3932ae5147a3d73dc70f1545926a692930ed | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.63e-04 | 197 | 62 | 4 | 8a126cfe1529f3d75a806aa492743314a8a43ef9 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 197 | 62 | 4 | c84e988c2ad06087aafda9e3b68e9e72fd0e75f1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-04 | 197 | 62 | 4 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-04 | 197 | 62 | 4 | 9262785807faeb32417fad7ef202405053e453e2 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 197 | 62 | 4 | 6195f945b3fd6da07907619267d49e96d1044f8f | |
| ToppCell | 21-Trachea-Epithelial-Club-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 1.66e-04 | 198 | 62 | 4 | e735d82e5151c98b5724c543f8ad633c8ed824d2 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 198 | 62 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 198 | 62 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 199 | 62 | 4 | 92778939e9d06599c7d06cfd8f4362b97ed0606b | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.07e-06 | 197 | 62 | 7 | 5766_DN | |
| Disease | Malignant neoplasm of breast | 3.02e-04 | 1074 | 60 | 9 | C0006142 | |
| Disease | myeloperoxidase measurement | 1.28e-03 | 26 | 60 | 2 | EFO_0005243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LQSASPSTRWTELDD | 146 | Q9UMD9 | |
| EWRETGSSSASLLLD | 71 | Q96Q91 | |
| RPALLVSSTSWTEDE | 276 | Q9BT22 | |
| DLLSTKESWVEATPR | 1611 | P13611 | |
| EADALLPSLRTEVWT | 516 | Q96Q42 | |
| LWVRDSPASLEVASS | 266 | P49662 | |
| LTRSEELTLSEEATW | 86 | Q99933 | |
| WSTTLLSPRETDAAA | 341 | Q9Y2H0 | |
| SSPDIEEISLRSLFW | 1891 | Q5H9R4 | |
| DAALWLETLSDSRPA | 556 | O94823 | |
| TLTSPDLEGTWDTRD | 6 | O60393 | |
| DTLNRWSELTSPLDS | 1236 | Q9UPP5 | |
| DSLSTLDWDTGRSLS | 3731 | Q8WXI7 | |
| LSPSSDLTLSSVLWD | 266 | Q8WUM0 | |
| LTDEESLLSSWDFPR | 186 | O15479 | |
| LDSCSSPLLWTRLDE | 416 | Q8TD91 | |
| SPLLWTRLDEESSSE | 421 | Q8TD91 | |
| TLELRETSVTPSNLW | 76 | Q9H8Y8 | |
| TALSSDEEDLSSWLP | 206 | Q6P4R8 | |
| DEEDLSSWLPSSPAR | 211 | Q6P4R8 | |
| LESSTVWASTLPRDE | 3341 | Q03001 | |
| RSTTDETWDSPEELK | 931 | Q8IVL0 | |
| TLWSSLLPEEARDIT | 196 | A2RU67 | |
| SWDSLPDTSTTDRLD | 126 | Q96LR2 | |
| WLLEDSSRAELPVTD | 341 | P35658 | |
| NETSLILEWSEPRDL | 351 | P54753 | |
| SSTSNALSWLDEELL | 381 | Q9NZ52 | |
| EWTELLKLASSEPRT | 266 | Q8TE49 | |
| SEEDEDTTWTPTRLA | 491 | C9JSJ3 | |
| LEEEWLALDSTRFPS | 1446 | Q96JM4 | |
| SPASFLRSLEDSEWL | 1381 | O95248 | |
| PSWTDSELSSREPLE | 241 | Q8TB68 | |
| RSTADTLPDLEEWKS | 6 | Q9NSI5 | |
| DDTAWLSGLTSDPRE | 151 | Q9NWV8 | |
| EKDSVILSIWRPSSD | 2981 | P51587 | |
| SSSLIEETNEWPLES | 271 | O14981 | |
| SWAFTDRPDLSLTVL | 206 | O14523 | |
| TRSSLELDTELSWIS | 2211 | O43497 | |
| RPSPDSSESDWETLD | 321 | Q8NBF6 | |
| SSESDWETLDPSVLE | 326 | Q8NBF6 | |
| PSDLWSRSDGEAELL | 16 | Q9UN19 | |
| LEGSWSDISLSDIES | 701 | Q5U5Z8 | |
| PRDPTDSLDWLEALS | 366 | Q6ZN01 | |
| LDAPRWEALESLSQS | 206 | Q17RN3 | |
| VSDDKTLRIWDLSPS | 1016 | Q05BV3 | |
| SPARSEESLEWEKTT | 936 | Q16099 | |
| RESPLVSAWSEELIS | 551 | O95479 | |
| ESLLTDDVEISRWGS | 3396 | Q8IVF4 | |
| TPSEADRWLEEVSKS | 436 | P49757 | |
| TSENWDSLLLGELSD | 281 | O43189 | |
| WREEATFELPSLLSS | 66 | Q6WKZ4 | |
| ESLELSSPRSPETDW | 526 | Q9H4M7 | |
| DLSLPVSSLSSSDWI | 166 | Q96GI7 | |
| STSSEEEESWEPLRG | 621 | Q8IY81 | |
| SSDPSVTSPLDWLEE | 131 | Q5SWA1 | |
| TSLLELLSRDWPESS | 196 | Q7RTR0 | |
| LRWTPLTNSEESLDF | 71 | O95398 | |
| EALSLPTVRDWTLED | 501 | Q99592 | |
| PTVRDWTLEDSSQEL | 506 | Q99592 | |
| TDRTSDSLLLRWTVP | 1071 | P22105 | |
| TAALPRSTSLDRDWA | 1196 | Q6ZT07 | |
| IPALWEAEASRSLES | 96 | A0A2R8Y7D0 | |
| SDWRETLSLSPVRQD | 56 | Q8N446 | |
| TTETLEWRLGSSDIL | 171 | O14530 | |
| TPRLSSEAVSVLWDL | 146 | Q68DK2 | |
| PSLISWLEEEEELST | 156 | Q96MR9 | |
| PLSWEESTEHSSLAL | 1196 | Q70EL1 |